New vaccine ingredient shows promise
Their new research, published in Science Immunology, shows that a "combination" adjuvant called a saponin/TLR agonist may boost the protective power of vaccines.
Conferences & Events News
Modernise your Medical Affairs Insight Management with ViiV Healthcare, Eisai, ASC Therapeutics and Within3
9 December, 2021. 10AM EST, 3PM GMT, 4PM CET. Virtual Event.Medical affairs teams are challenged by rising costs and accelerated timelines - and hampered by inefficiency throughout the insight gathering process. These breakdowns occur before a single insight is collected: by engaging with the wrong KOLs, medical affairs won't access the right strategic insights while wasting time and effort.
Novartis, Bayer and Boehringer Ingelheim to showcase their commitment to a reimagined pharma industry
11 - 22 October, 2021, VirtualBoard level executives from Novartis, Bayer and Boehringer Ingelheim, amongst many more, will showcase their long-term visions for healthcare as a response to the COVID-19 pandemic, by joining the speaker faculty at Reuters Events Pharma Europe 2021.
Scientists urge for investment now in highly potent vaccines to prevent the next pandemic
In a commentary article published in the journal Nature, Dennis Burton, PhD, and Eric Topol, MD, of Scripps Research call for governments to provide significant funding support for rational vaccine design based on broadly neutralizing antibodies.
CPhI Worldwide to return in 2021
31 August - 2 September 2021, Milan, Italy.CPhI Worldwide will be held next year in Milan (Fiera Milano) for the first time in over a decade - following its postponement in 2020. The event returns at an apt moment, as the pharma industry in Italy is anticipated to be one of the main beneficiaries of geo-diverse sourcing strategies.
Reuters Events' Cell & Gene Therapy USA
2 November 2020, Virtual Event, USA.Join 2500+ gene and cell therapy leaders for this (free to attend) conference brough to you by Reuters Events.
The race to commercialize cell & gene therapies (CGT) is heating up. Almost all of top 20 pharma have dedicated strategies, while US policy makers and the FDA are facilitating innovation and accelerating pathways to market.
Total health: Build a better healthcare system
19 - 20 November, 2020. Digital Forum, #REhealthcare.The stage is set for a paradigm shift in healthcare. The opportunity exists to redefine healthcare in a way that transforms patient outcomes, drives efficiency and changes lives.
Reuters Events Total Health will unite CEOs, innovators, disruptors and policy makers from across the healthcare ecosystem to seize upon this critical moment.
More Pharma News ...
Business & Industry
- GSK and Vir Biotechnology announce United States government agreement to purchase additional supply of sotrovimab
- New Vaxzevria data further support its use as third dose booster
- Novartis and Molecular Partners report positive topline data from Phase 2 study for ensovibep (MP0420), a DARPin antiviral therapeutic for COVID-19
- Amgen and Arrakis Therapeutics announce multi-target collaboration to identify novel RNA degrader small molecule therapeutics
- Bayer and Mammoth Biosciences to collaborate on novel gene editing technolog
Research & Development
- WHO recommends two new drugs to treat patients with COVID-19
- Research team finds new dual benefit mode of action for a drug candidate to fight COVID-19
- COVID-19 - Omicron: resistant to most monoclonal antibodies but neutralized by a booster dose
- COVID-19 can trigger self-attacking antibodies
- Treatments in weeks, not months: Scientists develop ambitious pandemic response plan
- Scientists identify antibodies that can neutralize omicron
- Stopping dementia at the nose with combination of rifampicin and resveratrol
Conferences & Events
- New vaccine ingredient shows promise
- Modernise your Medical Affairs Insight Management with ViiV Healthcare, Eisai, ASC Therapeutics and Within3
- Novartis, Bayer and Boehringer Ingelheim to showcase their commitment to a reimagined pharma industry
- Scientists urge for investment now in highly potent vaccines to prevent the next pandemic
- CPhI Worldwide to return in 2021
- Reuters Events' Cell & Gene Therapy USA
- Total health: Build a better healthcare system
Regulatory Affairs
- FDA authorizes additional oral antiviral for treatment of COVID-19 in certain adults
- FDA authorizes first oral antiviral for treatment of COVID-19
- FDA expands eligibility for Pfizer-BioNTech COVID-19 booster dose to 16- and 17-year-olds
- FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in children 5 through 11 years of age
- FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases